Organogenesis Celebrates Launch of Advancing Healing Education Resource Center and Highlights Latest Wound Care Research at SAWC Fall 2018

November 7, 2018
PR Newswire

Organogenesis Inc., a leading regenerative medicine company committed to empowering healing, will celebrate the launch of the Advancing Healing Education Resource Center, a continuing medical education microsite covering the latest clinical and practical developments in wound healing, as well as showcase the company’s latest product research during the Symposium on Advanced Wound Care (SAWC) Fall 2018 meeting held this week in Las Vegas.

Read More

How wounds heal and why it takes longer as you get older

November 6, 2018
ABC Science

In the split second after I tripped while out running on the weekend, I knew I was going to do an excellent job of skinning my knee. And I did. I skidded down the gravelly track, sprawled on my belly, coming to a stop a couple of metres from the tree root that I had failed to see in time.

Read More

Obese mice lose a third of their fat using a natural protein

November 6, 2018
Eureka Alert!

To the great surprise of cancer researchers, a protein they investigated for its possible role in cancer turned out to be a powerful regulator of metabolism. The Georgetown University-led study found that forced expression of this protein in a laboratory strain of obese mice showed a remarkable reduction of their fat mass despite a genetic predisposition to eat all the time.

Read More

Photosynthetic sutures promote wound healing

November 6, 2018
Physics World

Sutures are extensively used to close wounds. However, rather than promoting active healing of the wound, they act as a passive element that provokes scar formation. In addition, the disruption of blood vessels decreases the presence of oxygen in the wound, limiting the healing.

Read More

UCLA-Based Scarless Labs Wins FDA Approval to Study Scar Healing Treatment

November 6, 2018
Los Angeles Business Journal

Scarless Laboratories Inc., an early stage biotechnology company based at UCLA, has received federal clearance to conduct two clinical studies of its patented compound to heal scar tissue. The 14-year-old company said the U.S. Food and Drug Administration had given a green light for a phase I and phase II trial to study a peptide to promote wound healing and improve scar appearance.

Read More